About us
„Präklinische Identifikation von Wirkmechanismus und Zielidentifikation für T03-04“
Das Projekt erforscht die Wirkungsweise sowie den Wirkmechanismus der neuen, patentgeschützten chemischen Substanzen Treamid03 und Treamid04.
Die Moleküle sollen hinsichtlich ihres therapeutischen Potenzials bei der Behandlung inflammatorischer Atemwegserkrankungen untersucht werden.
Das Projekt wird im Rahmen des IBB Programms Pro FIT durch den Europäischen Fonds für regionale Entwicklung (EFRE) kofinanziert.
Sponsored by
Address
Registered Office / Firmensitz:
Treamid Therapeutics GmbH
Robert-Rössle-Str. 10
Haus 80 (Otto-Warburg-Haus)
13125 Berlin, Deutschland
Managing Director / Geschäftsführer:
Vladimir Nebolsin
Contacts
info@treamid.com
Registered at the municipal court Charlottenburg in Berlin/
Eingetragen beim Amtsgericht Charlottenburg in Berlin
HRB 186965 B
VAT-No./USt-ID./Nr.: DE312658431
Disclaimer
This website provides general information about our company, its products and services. Due to the nature of our products and services they may be subject to change and some of them are provided only regionally or with a regional difference as reflected by their customized nature. Our webpage and its contents do not purport to convey medical advice, and on no account is it a substitute for a consultation with a medical practitioner. The attention of users of our products is drawn to the directions for use accompanying the product. All content is prepared with the greatest possible care and is subject to constant updates and additions. We accept no liability for any errors arising, nor for the continuing relevance of the content to the current situation. We accept no liability for third-party content quoted by us on this website or to which we refer through hyperlinks. The content of this website is intended for users within the European Union and has been prepared by us under the provisions of German law. We do not guarantee the legality of this website under the jurisdiction of other countries. All copyright for the content of this website is vested in our company. The application of this material for commercial purposes is permitted only with our prior authorization.